在心脏手术患者中探索维生素K,肠道微生物群和华法林变异性之间的复杂关系
Ling Xue1,2, Rajeev K Singla3,4, Qiong Qin1
1Department of Pharmacy.
International journal of surgery (London, England)
|August 20, 2023
概括
维生素K度和肠道微生物群显著影响心脏手术患者的华法林剂量变化. 增加的维生素K可能会降低抗凝,而特定的肠道细菌会影响华法林.
科学领域:
- 药物基因组学 药物基因组学
- 微生物组研究 微生物组研究
- 心血管药理学心血管药理学
背景情况:
- 华法林在抗凝剂反应中表现出高度的个体间变异性.
- 了解影响华法林疗效的因素对于患者安全至关重要.
研究的目的:
- 研究维生素K水平和肠道微生物群对华法林变异性的影响.
- 为了确定与心脏手术患者的华法林反应相关的特定细菌物种.
主要方法:
- 药理动力学-药理动力学 (PKPD) 建模用于预测华法林的作用.
- 对血清和便样本进行维生素K (VK1,MK4) 和肠道微生物组合的分析.
- 对包括基因型 (CYP2C9,VKORC1,CYP4F2) 在内的患者数据的审查.
主要成果:
- 增加的维生素K度与减少的抗凝血相关.
- 鉴定出Prevotella和Eubacterium是影响华法林变异性的关键肠道细菌.
- 肠道微生物群可能会通过维生素K2合成影响华法林抗凝作用.
结论:
- 维生素K状态和肠道微生物组合是华法林处方的关键因素.
- 这些发现支持个性化华法林治疗,考虑个人维生素K和肠道微生物群概况.
- 需要进一步的研究来阐明维生素K和肠道微生物群在华法林抗凝剂中的精确机制.
相关概念视频
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Vitamins
774
Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced...
774
Venous Thrombosis III: Interprofessional Care
10
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
Drug Absorption: Factors Affecting GI Absorption
4.1K
The process of oral drug absorption can be influenced by several factors. Weakly acidic drugs tend to be absorbed more readily from the stomach due to their nonionized state. However, absorption may be less efficient in the upper intestine, where drugs are often ionized. Interestingly, despite the stomach's apparent advantage for drug absorption, its mucous layer can hinder diffusion. Its surface area is also smaller than the intestine's, which can further slow down the absorption rate.
4.1K
Factors Affecting the Risk of Infection
11.9K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
11.9K
Factors Affecting Drug Biotransformation: Biological
177
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
177


